Lithium, a GSK-3β inhibitor and autophagy modulator, has demonstrated pro-repair and anti-inflammatory effects in preclinical gut models, including enhanced mucosal regeneration after DSS colitis and attenuation of experimental colitis via microbiota- and Treg-dependent mechanisms [71,72]. Here, GSK3B is linked to colitis.